We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

38 hedge funds and large institutions have $59.1M invested in Redhill Biopharma in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 5

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

45% more capital invested

Capital invested by funds: $40.7M → $59.1M (+$18.4M)

27% more funds holding

Funds holding: 30 → 38 (+8)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
38
Holders Change
+8
Holders Change %
+26.67%
% of All Funds
0.87%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
13
Increased
12
Reduced
5
Closed
5
Calls
$214K
Puts
–
Net Calls
+$214K
Net Calls Change
+$51K

Top Buyers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
+$12.9M
2
Millennium Management
Millennium Management
New York
+$1.24M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.13M
4
MC
Menta Capital
California
+$701K
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
+$334K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$2.28M
2
AIM
ARK Investment Management
Florida
-$521K
3
AS
Altshuler Shaham
Israel
-$212K
4
EDRH
Edmond de Rothschild Holding
Switzerland
-$156K
5
CBU
CIBC Bank USA
Illinois
-$65.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
CBU
26
CIBC Bank USA
Illinois
$106K -$65.2K -8 -40%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$106K – – –
ARTA
28
A.R.T. Advisors
New York
$101K +$97.8K +12 New
DWM
29
Dorchester Wealth Management
Quebec, Canada
$88K +$81.5K +10 New
VanEck Associates
30
VanEck Associates
New York
$67K +$8.15K +1 +14%
UBS Group
31
UBS Group
Switzerland
$62K +$32.6K +4 +133%
PVH
32
Psagot Value Holdings
Israel
$53K +$40.7K +5 +500%
Bank of America
33
Bank of America
North Carolina
$26K +$16.3K +2 +200%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$26K +$24.4K +3 New
Group One Trading
35
Group One Trading
Illinois
$13K +$8.15K +1 New
IP
36
Intellectus Partners
California
$9K – – –
Wells Fargo
37
Wells Fargo
California
$8K – – –
SPIA
38
Steward Partners Investment Advisory
New York
$4K +$8.15K +1 New
CG
39
Cutler Group
California
$2K – – –
AS
40
Altshuler Shaham
Israel
$1K -$212K -26 Closed
Simplex Trading
41
Simplex Trading
Illinois
$1K – – –
EDRH
42
Edmond de Rothschild Holding
Switzerland
– -$156K -18 Closed
FFW
43
Fusion Family Wealth
New York
– -$43K -5 Closed
LTFS
44
Ladenburg Thalmann Financial Services
Florida
– -$23K -5 Closed
B
45
Bridgeworth
Alabama
– -$8K -1 Closed
1
2

RDHL Hedge Fund Activity: Q3 2018 in Review

38 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2018, worth a combined $59.1M — up 45% from $40.7M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new RDHL positions and 5 closed out — a net gain of 8 holders — while 12 added to existing stakes and 5 trimmed.

The largest buyer was 683 Capital Management, adding an estimated $12.9M. The largest seller was OrbiMed, cutting an estimated $2.28M.

  • 38 institutional investors held Redhill Biopharma (RDHL) as of Q3 2018, up from 30 in Q2 2018.
  • Funds reported $59.1M of Redhill Biopharma stock for Q3 2018, up 45% quarter-over-quarter.
  • 13 funds opened new Redhill Biopharma positions in Q3 2018 and 5 closed out, a net change of +8 holders.
  • The largest Redhill Biopharma buyer in Q3 2018 was 683 Capital Management, an estimated $12.9M added.
  • The largest Redhill Biopharma seller in Q3 2018 was OrbiMed, an estimated $2.28M sold.

Based on aggregated 13F filings for Q3 2018.